Showing results (1521-1530 of 9,902) with videos related to

Sort By:
Pageof 991
Bone Marrow Transplantation|January 21, 2025
Impact of TP53 alteration on allogeneic hematopoietic cell transplantation outcomes for myelodysplastic syndromesCuiyan Zhou, Lanping Xu, Xiaohui Zhang, et al.
Bone Marrow Transplantation|January 25, 2025
Identification of the conditions and minimum requirements necessary for the release of autologous fresh CAR T-cell products under hospital exemption: a position paper from the WP-bioproduction of the UNITC consortiumOlivier Boyer, Daniele Bensoussan, Halvard Bönig, et al.
Bone Marrow Transplantation|January 14, 2025
Safety and efficacy of the ROCK-2-inhibitor Belumosudil in cGvHD treatment - a retrospective, German-Swiss multicenter real-world data analysisSilke Heidenreich, Katharina Egger-Heidrich, Jörg P Halter, et al.
Bone Marrow Transplantation|March 12, 2025
Early morbimortality in autologous hematopoietic cell transplantation performed on outpatient basis in patients with autoimmune diseases: experience in 1700 patientsOlivia Lira-Lara, Max Robles-Nasta, Juan Carlos Olivares-Gazca, et al.
Bone Marrow Transplantation|April 8, 2025
GvHD prophylaxis with tacrolimus, sirolimus, and mycophenolate mofetil after reduced intensity conditioning hematopoietic stem cell allogeneic transplantationL Lopez-Corral, C Blázquez-Goñi, E Pérez-López, et al.
Bone Marrow Transplantation|April 10, 2025
Impact of center volume on outcomes in allogeneic hematopoietic cell transplantation for childrenMotohiro Kato, Hideki Nakashone, Keitaro Matsuo, et al.
Bone Marrow Transplantation|December 11, 2024
Ruxolitinib in acute and chronic graft-versus-host disease: real life long-term experience in a multi-center study for adult and pediatric patients, on behalf of the GETH-TCVirginia Escamilla-Gómez, Valentín García Gutiérrez, Patricia Alcalde-Mellado, et al.
Bone Marrow Transplantation|December 11, 2024
Pre-engraftment bloodstream infection after allogeneic haematopoietic cell transplant: 18-year trends in aetiology, resistance and mortalityAnna Falcó-Roget, Anna Maria Raiola, Elisa Balletto, et al.
Bone Marrow Transplantation|November 20, 2024
Measurable residual disease testing and allogeneic hematopoietic cell transplantation for AML: adapting Pre-MEASURE to clinical practiceBrian C Shaffer, Partow Kebriaei, Marcos de Lima, et al.
Bone Marrow Transplantation|November 20, 2024
Immunological reconstitution and infections after alloHCT - a comparison between post-transplantation cyclophosphamide, ATLG and non-ATLG based GvHD prophylaxisThomas Meyer, Kristina Maas-Bauer, Ralph Wäsch, et al.
Pageof 991